Jpmorgan Chase & CO Zynex Inc Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Zynex Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 93,995 shares of ZYXI stock, worth $129,713. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93,995
Previous 42,997
118.61%
Holding current value
$129,713
Previous $344,000
40.12%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding ZYXI
# of Institutions
77Shares Held
5.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.24MShares$1.72 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA948KShares$1.31 Million0.0% of portfolio
-
Janney Montgomery Scott LLC440KShares$607,4440.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny299KShares$411,9980.0% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA248KShares$341,8230.0% of portfolio
About ZYNEX INC
- Ticker ZYXI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Distribution
- Shares Outstandng 37,453,400
- Market Cap $51.7M
- Description
- Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...